Research ArticleClinical Investigations
Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-l-Tyrosine PET in Comparison to MRI
Norbert Galldiks, Karl-Josef Langen, Richard Holy, Michael Pinkawa, Gabriele Stoffels, Kay W. Nolte, Hans J. Kaiser, Christan P. Filss, Gereon R. Fink, Heinz H. Coenen, Michael J. Eble and Marc D. Piroth
Journal of Nuclear Medicine July 2012, 53 (7) 1048-1057; DOI: https://doi.org/10.2967/jnumed.111.098590
Norbert Galldiks
Karl-Josef Langen
Richard Holy
Michael Pinkawa
Gabriele Stoffels
Kay W. Nolte
Hans J. Kaiser
Christan P. Filss
Gereon R. Fink
Heinz H. Coenen
Michael J. Eble

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 53, Issue 7
July 1, 2012
Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-l-Tyrosine PET in Comparison to MRI
Norbert Galldiks, Karl-Josef Langen, Richard Holy, Michael Pinkawa, Gabriele Stoffels, Kay W. Nolte, Hans J. Kaiser, Christan P. Filss, Gereon R. Fink, Heinz H. Coenen, Michael J. Eble, Marc D. Piroth
Journal of Nuclear Medicine Jul 2012, 53 (7) 1048-1057; DOI: 10.2967/jnumed.111.098590
Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-l-Tyrosine PET in Comparison to MRI
Norbert Galldiks, Karl-Josef Langen, Richard Holy, Michael Pinkawa, Gabriele Stoffels, Kay W. Nolte, Hans J. Kaiser, Christan P. Filss, Gereon R. Fink, Heinz H. Coenen, Michael J. Eble, Marc D. Piroth
Journal of Nuclear Medicine Jul 2012, 53 (7) 1048-1057; DOI: 10.2967/jnumed.111.098590
Jump to section
Related Articles
Cited By...
- Amino Acid PET in Neurooncology
- Amino Acid PET in Neurooncology
- Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
- Early Treatment Response Assessment Using 18F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy
- Treatment Monitoring of Immunotherapy and Targeted Therapy Using 18F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences
- Influence of Bevacizumab on Blood-Brain Barrier Permeability and O-(2-18F-Fluoroethyl)-L-Tyrosine Uptake in Rat Gliomas
- Combined PET Imaging of the Inflammatory Tumor Microenvironment Identifies Margins of Unique Radiotracer Uptake
- Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM
- Clinical Impact of Amino Acid PET in Gliomas
- Comparison of 18F-FET PET and Perfusion-Weighted MR Imaging: A PET/MR Imaging Hybrid Study in Patients with Brain Tumors
- Diagnostic Performance of 18F-FET PET in Newly Diagnosed Cerebral Lesions Suggestive of Glioma